Immunoglobulin G fragment C receptor polymorphisms and KRAS mutations: are they useful biomarkers of clinical outcome in advanced colorectal cancer treated with anti-EGFR-based therapy?

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples